These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 1713020)
21. E-cadherin expression in gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study. Swami S; Kumble S; Triadafilopoulos G Am J Gastroenterol; 1995 Oct; 90(10):1808-13. PubMed ID: 7572899 [TBL] [Abstract][Full Text] [Related]
22. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma. Kim CH; Kim J; Kahng H; Choi EC Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073 [TBL] [Abstract][Full Text] [Related]
23. Frequent hypermethylation of the 5' CpG island of E-cadherin in esophageal adenocarcinoma. Corn PG; Heath EI; Heitmiller R; Fogt F; Forastiere AA; Herman JG; Wu TT Clin Cancer Res; 2001 Sep; 7(9):2765-9. PubMed ID: 11555590 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of E-cadherin protein in metastatic breast cancer cells in bone. Saha B; Chaiwun B; Imam SS; Tsao-Wei DD; Groshen S; Naritoku WY; Imam SA Anticancer Res; 2007; 27(6B):3903-8. PubMed ID: 18225549 [TBL] [Abstract][Full Text] [Related]
25. Novel monoclonal antibodies detect Smad-interacting protein 1 (SIP1) in the cytoplasm of human cells from multiple tumor tissue arrays. Oztas E; Avci ME; Ozcan A; Sayan AE; Tulchinsky E; Yagci T Exp Mol Pathol; 2010 Oct; 89(2):182-9. PubMed ID: 20515682 [TBL] [Abstract][Full Text] [Related]
26. Altered expression and function of E-cadherin in cervical intraepithelial neoplasia and invasive squamous cell carcinoma. Vessey CJ; Wilding J; Folarin N; Hirano S; Takeichi M; Soutter P; Stamp GW; Pignatelli M J Pathol; 1995 Jun; 176(2):151-9. PubMed ID: 7636625 [TBL] [Abstract][Full Text] [Related]
27. Expression of E-cadherin is associated with squamous differentiation in squamous cell carcinomas. Wu H; Lotan R; Menter D; Lippman SM; Xu XC Anticancer Res; 2000; 20(3A):1385-90. PubMed ID: 10928048 [TBL] [Abstract][Full Text] [Related]
28. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer. Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343 [TBL] [Abstract][Full Text] [Related]
29. Expression of E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: an immunohistochemical study. Hidaka N; Nagao T; Asoh A; Kondo Y; Nagao K Mod Pathol; 1998 Nov; 11(11):1039-45. PubMed ID: 9831199 [TBL] [Abstract][Full Text] [Related]
30. [Expression of annexin I in different histological types of carcinomas]. Xue LY; Teng LH; Zou SM; Ren LQ; Zheng S; Luo W; Bi R; Lü N Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):444-8. PubMed ID: 17974280 [TBL] [Abstract][Full Text] [Related]
31. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Zhang H; Stephens LC; Kumar R Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771 [TBL] [Abstract][Full Text] [Related]
32. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Moll R; Mitze M; Frixen UH; Birchmeier W Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859 [TBL] [Abstract][Full Text] [Related]
33. Persistent E-cadherin expression in inflammatory breast cancer. Kleer CG; van Golen KL; Braun T; Merajver SD Mod Pathol; 2001 May; 14(5):458-64. PubMed ID: 11353057 [TBL] [Abstract][Full Text] [Related]
34. Correlation between E-cadherin expression and invasiveness in vitro in a human esophageal cancer cell line. Doki Y; Shiozaki H; Tahara H; Inoue M; Oka H; Iihara K; Kadowaki T; Takeichi M; Mori T Cancer Res; 1993 Jul; 53(14):3421-6. PubMed ID: 8324752 [TBL] [Abstract][Full Text] [Related]
35. Functional allelic loss detected at the protein level in archival human tumours using allele-specific E-cadherin monoclonal antibodies. Becker KF; Kremmer E; Eulitz M; Schulz S; Mages J; Handschuh G; Wheelock MJ; Cleton-Jansen AM; Höfler H; Becker I J Pathol; 2002 Aug; 197(5):567-74. PubMed ID: 12210074 [TBL] [Abstract][Full Text] [Related]
36. The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients' survival. Lazăr D; Tăban S; Ardeleanu C; Dema A; Sporea I; Cornianu M; Lazăr E; Vernic C Rom J Morphol Embryol; 2008; 49(4):459-67. PubMed ID: 19050793 [TBL] [Abstract][Full Text] [Related]
37. [Correlation among expression of E-cadherin, beta-catenin, and cyclin D1 in breast cancers]. Yang JF; Chen SL; Liu ZH; Zhang Y Ai Zheng; 2004 Jul; 23(7):799-802. PubMed ID: 15248915 [TBL] [Abstract][Full Text] [Related]
38. Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells. Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR Eur Surg Res; 2007; 39(4):208-15. PubMed ID: 17396032 [TBL] [Abstract][Full Text] [Related]
39. Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis. Saito T; Masuda N; Miyazaki T; Kanoh K; Suzuki H; Shimura T; Asao T; Kuwano H Oncol Rep; 2004 Mar; 11(3):605-11. PubMed ID: 14767510 [TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer. Ohno T; Aihara R; Kamiyama Y; Mochiki E; Asao T; Kuwano H Eur J Cancer; 2006 Jan; 42(2):256-63. PubMed ID: 16356709 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]